2019 Conference Agenda
 
Wednesday Thursday Friday
 
Tuesday, May 28, 2019
6:00 - 8:00 pm "Welcome to Boston"- COCKTAIL RECEPTION
 
 
Wednesday, May 29, 2019
7:15 - 8:30 am BREAKFAST
8:30 - 9:00 am Welcome | Day One Introductions and Announcements
  2019 Boston Conference Chairman: Justin Renz, President & CFO, Correvio Pharmaceuticals, Inc.
9:00 - 10:15 am KEYNOTE PRESENTATION: "Government and Policy"
    Speakers: Jon Chesto, Reporter, Boston Globe
10:15 -10:30 am Break
10:30 -12:00 pm KEYNOTE SPEAKER: Mike Eruzione, Captain, 1980 US Gold Medal Olympic Team, "Miracle on Ice"
   
12:00 - 1:15 pm LUNCH
1:15 - 2:15 pm Technical Accounting Update - Ernst & Young LLP
  Update on the latest accounting developments that are expected to impact bioscience companies. EY will share their insights on how the matters are being interpreted, what bioscience companies should be focused on, and how the various regulatory bodies view these areas.
    Moderator: Michael Formolo, Partner, Ernst & Young, LLP
2:15 - 3:15 pm PANEL PRESENTATION: CFO ROUNDTABLE
   
    Moderator:
Panelists:
Iain Brown, Senior Vice President of Finance, Chief Accounting Officer, Alkermes Inc.
Lorence Kim
, Chief Financial Officer, Modera Therapeutics
Jim Frates,
Chief Financial Officer, Alkermes, Inc.
TBD
3:15 -3:30 am Break
3:30 - 4:30 pm KEYNOTE PRESENTATION: Kevin Gillis, "Private to Public Life Style Transition"
    Moderator:
Panelists:
Kevin Gillis, Partner, Chief Financial Officer, Third Rock Ventures
Mike Landsittel
, Vice President, Finance, Blueprint Medicines
Yasir Al-Wakeel,
Chief Financial Officer, Neon Therapeutics, Inc.
Cindy Driscoll,
Vice President, Finance, Magenta Therapeutics, Inc.
4:30 - 5:30 pm "Cybersecurity & Crypto-currency"
   
    Moderator:
Panelists:
Kristin Kraeger, Managing Director, AON
Laura Armstrong, Sr. Manager, Ernst & Young, LLP
Jim Trainor, Senior Vice President, AON, former Assistant Director, Cyber Division, Federal Bureau of Investigation
Mary Rosendahl, eChannel Product Manager,Bank of America Merrill Lynch
5:40 pm Evening Social Event and Networking - Cocktail Hour, Walk to Fenway Park, Boston Red Sox vs. Cleveland Indians, game starts at 7:10 pm
       
       
Thursday, May 30
7:15 - 8:30 am BREAKFAST
8:30 - 9:00 am Welcome | Day Two Introductions and Announcements
  2020 San Diego Conference Chairman:  
9:00 - 10:15 am KEYNOTE SPEAKER: Robert Coughlin, President & CEO, Massachusetts Biotech Counsel, "My Journey as Father, Patient Advocate and CEO of MassBio"
   
10:15 - 10:30 am Break
10:30 - 11:30 pm KEYNOTE PRESENTATION: "Women in Leadership"
   
    Moderator:
Panelists:
Sarah Larson, Partner, Third Rock Ventures
Kim Draphkin, Chief Financial Officer, Jounce Therapeutics, Inc.
Kimi Iguchi, Chief Financial Officer, Sage Therapeutics, Inc.
11:30 - 12:15 pm PANEL DISCUSSION: "Women in Leadership"
    Panelists: Cissy Young, Managing Director, Russell Reynolds
Rose Mistri-Somers, Rose Reynolds Associates
TBD
12:15 - 1:15 pm LUNCH [Regional Coordinators' Meeting]
1:15 - 2:15 pm KEYNOTE SPEAKER: Solomon Wilcots, NFL Broadcaster/Leader, Russo Partners' Sports-Health Alliance, "How Preparation Eliminates Pressure"
  Short Break to Change Rooms
2:15 - 3:15 pm PANEL PRESENTATIONS - Select One
    A. Compensation
An interactive session organized by AON that will delve into the latest news to come out of ISS, the SEC and others, as well as what Radford has observed this year in interactions with board, management and proxy advisors. The presenters will discuss corporate guidelines and regulatory development in compensation.
    B. XBRL Use This presentation, overseen by Toppan Merrill, will cover how the use of XBRL is reaching a tipping point and revolutionizing how the SEC and investing community is benefitting by its use. Participants will  learn how users of this data, especially the SEC, can effectively compare filings for abnormalities, patterns, outliers, or other trends that could indicate misconduct, and give the SEC insight into issues of which a Registrant may not even be aware.
    C. Financial and Resource Management in LIfe Sciences, Challenges and Best Practices This breakout session, presented with the assistance of R&D Logic, will include:
  • Trends and Industry Methodologies
  • How to ensure buy-in on RD budgeted costs from stakeholders
  • Pitfalls of planning for R&D activities and to to overcome them
  • Best practices, FP&A automation, technical platforms.
  Short Break to Change Rooms
3:15 - 4:15 pm COMPANY ROUNDTABLES - Select One
  These company roundtables will be facilitated by Pepper Hamilton, LLP along with carefully selected CFOs from each of the company stages with the aim of providing a forum for thoughtful discussion of the issues relevant to each.
    Early Stage Companies  
    Late Stage Companies  
    Commercialized Companies  
4:15 - 4:30 pm Break
4:30 -5:30 pm PANEL PRESENTATION - "Product Launches/Reimbursement"
    Moderator: Brendan McCorry, Partner, Ernst & Young, LLP
  15 Minute Break Before Evening Special Event
5:45 pm Thursday Evening Special Event - Buses to leave at 5:45 pm
 
Friday, May 31, 2019
7:15 - 8:45 am BREAKFAST
8:45 - 9:00 am Welcome | Day Three Introductions and Announcements
2019 Boston Conference Chairman: Justin Renz, President & CFO, Correvio Pharmaceuticals, Inc.
9:00 - 10:15 am KEYNOTE SPEAKER: Joseph Quinlan, Managing Director & Chief Market Strategist, US Trust, Bank of America, Private Wealth Management
   
10:15 - 10:30 am Break
10:30 - 11:30 am PANEL PRESENTATION: "From the CFO to the Boardroom"
    Moderator:
Panelists:
Cissy Young, Managing Director, Russell Reynolds
Rose Mistri-Somers, Russell Reynolds
TBD
11:30 am Conference Concludes
       
       
Back to Top